(24/7 MARKET NEWS) – Virax Biolabs (NASDAQ: VRAX) is gaining in this morning’s premarket, trading at $2.88, up 0.41 (+16.60%), on over 800 thousand premarket shares, on Monkeypox testing news.
Since going public, about two months ago, this one’s mostly trended down, so it may be best to treat today’s move as a repeat of its September 1st move, as its 52- week range is $2.42 to $29.00
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.